Public research preview

Carol Devine Miller, Representative disclosure: Quest Diagnostics Incorporated Common Stock (DGX)

Disclosed a buy transaction in Quest Diagnostics Incorporated Common Stock (DGX). Use this page to inspect source evidence, confidence scores, filing delay, and post-disclosure price movement before deciding whether to research the signal further.

Copy Window
Probably too late
0/100
Signal Quality
63/100
Data quality
93%
High quality

This public page is for public-disclosure research only. It is not investment advice and does not place orders. Verify the official source before relying on any signal.

Evidence passport

Official-source context and parser confidence before any simulation or alert decision.

Source
House STOCK Act disclosures
Published
2 Sept 2022, 00:00
Parser confidence
94%
Instrument mapping
95%
Filing delay
401 days

Timeline

Transaction date

28 Jul 2021

Public disclosure

2 Sept 2022

Now

Tracked today

Filing delay: 401 days

Price movement

Complete coverage

Provider
Yahoo Finance daily close
Fetched
10 Jun 2026

The pre-disclosure spike has collapsed -26.6% from its peak. Retraces deeper than 20% behaved like falling knives in the backtests, not discounts, and are excluded from the discount-entry sleeve.

Stock path

DGX from pre-transaction context through latest close.

Bought

28 Jul 2021 · 127.522 USD · Not public yet

System decision

Would not buyThe strategy's filters reject this signal. Failed filters: Filed within 30 days.

Not public yetWould not buy113162211USDDate28 Jul2 Sept8 JunOfficial disclosure2 SeptBoughtDisclosureLatest
  • Not public yet
  • Would not buy
Observed transaction close
127.522
Observed disclosure close
116.126
Observed latest close
197.21
Pre-disclosure move
-8.9%
Post-disclosure move
+69.8%
Market-adjusted move
+69.8%
1w since disclosure
+3.9%
1m since disclosure
+0.8%
3m since disclosure
+22.6%
Pre-disclosure peak run-up
+24.1%
Retrace from peak
-26.6%

Why Copy Window is Probably too late

Supporting factors

  • Parsed buy disclosure for ordinary shares from House STOCK Act disclosures.
  • Reported amount is $15,001 - $50,000.
  • Post-disclosure move is calculated from Yahoo Finance daily close daily closes.

Cautions

  • Yahoo Finance daily close coverage is end-of-day and should be verified against the official price source.
  • Review the original source document before making any investment decision.

Source document

House STOCK Act disclosures, published 2 Sept 2022, 00:00

View source
Parser confidence
94%
Instrument mapping
95%
FieldExtracted value
roleRepresentative
sidebuy
value15001
sourcehouse_stock_act
tickerDGX
chamberHouse
currencyUSD
assetTypestock
sourceUrlhttps://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2022/20021633.pdf
personNameCarol Devine Miller
amountRange$15,001 - $50,000
companyNameQuest Diagnostics Incorporated (DGX)
publishedAt2022-09-02T00:00:00.000Z
rawDocumentIdraw-us-house-20021633-16
disclosureDate2022-09-02
transactionDate2021-07-28
transactionTypeP
Quest Diagnostics Incorporated Common Stock (DGX) disclosure research | CopyWindow